Dynavax Technologies Corporation – OTC:DVAXW
Dynavax Technologies stock price today
Dynavax Technologies key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | 221.00M |
EBITDA | -59.11M |
Income | -94.79M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -26.75% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDynavax Technologies stock price history
Dynavax Technologies stock forecast
Dynavax Technologies financial statements
| Sep 2020 | 13.41M | 4.40M | 32.81% |
|---|---|---|---|
| Dec 2020 | 46.55M | -75.24M | -161.63% |
| Jun 2021 | 52.76M | 4.47M | 8.48% |
| Sep 2021 | 108.27M | -28.43M | -26.26% |
| Sep 2020 | 353395000 | 284.11M | 80.39% |
|---|---|---|---|
| Dec 2020 | 353272000 | 294.57M | 83.39% |
| Jun 2021 | 647909000 | 564.52M | 87.13% |
| Sep 2021 | 919711000 | 852.13M | 92.65% |
| Sep 2020 | -27.82M | -2.05M | 1.41M |
|---|---|---|---|
| Dec 2020 | -15.74M | 14.34M | 66K |
| Jun 2021 | 110.78M | -63.75M | 3.33M |
| Sep 2021 | 66.21M | 45.67M | 5.32M |
Dynavax Technologies alternative data
| Aug 2023 | 245 |
|---|---|
| Sep 2023 | 245 |
| Oct 2023 | 245 |
| Nov 2023 | 245 |
| Dec 2023 | 245 |
| Jan 2024 | 245 |
| Feb 2024 | 245 |
| Mar 2024 | 245 |
| Apr 2024 | 245 |
| May 2024 | 245 |
| Jun 2024 | 245 |
| Jul 2024 | 245 |
Dynavax Technologies other data
| Period | Buy | Sel |
|---|---|---|
| Feb 2021 | 0 | 42155 |
| Mar 2021 | 0 | 5309 |
| Apr 2021 | 0 | 20000 |
| Jun 2021 | 0 | 2916250 |
| Aug 2021 | 0 | 4408268 |
| Sep 2021 | 0 | 40900 |
| Oct 2021 | 0 | 20000 |
| Nov 2021 | 0 | 20000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | NOVACK DAVID F officer: Presiden.. | Common Stock | 20,000 | $20.12 | $402,400 | ||
Sale | NOVACK DAVID F officer: Presiden.. | Common Stock | 20,000 | $20.12 | $402,400 | ||
Sale | NOVACK DAVID F officer: Presiden.. | Common Stock | 3,000 | $18 | $54,000 | ||
Sale | NOVACK DAVID F officer: Presiden.. | Common Stock | 3,000 | $18 | $54,000 | ||
Sale | NOVACK DAVID F officer: Presiden.. | Common Stock | 17,000 | $18.23 | $309,842 | ||
Sale | NOVACK DAVID F officer: Presiden.. | Common Stock | 17,000 | $18.23 | $309,842 | ||
Sale | JANSSEN ROBERT officer: Senior V.. | Common Stock | 900 | $20.15 | $18,135 | ||
Sale | JANSSEN ROBERT officer: Senior V.. | Common Stock | 900 | $20.15 | $18,135 | ||
Option | JANSSEN ROBERT officer: Senior V.. | Common Stock | 900 | $10.47 | $9,423 | ||
Option | JANSSEN ROBERT officer: Senior V.. | Common Stock | 900 | $10.47 | $9,423 |
-
What's the price of Dynavax Technologies stock today?
One share of Dynavax Technologies stock can currently be purchased for approximately $7.38.
-
When is Dynavax Technologies's next earnings date?
Unfortunately, Dynavax Technologies's (DVAXW) next earnings date is currently unknown.
-
Does Dynavax Technologies pay dividends?
No, Dynavax Technologies does not pay dividends.
-
What is Dynavax Technologies's stock symbol?
Dynavax Technologies Corporation is traded on the OTC under the ticker symbol "DVAXW".
-
What is Dynavax Technologies's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Dynavax Technologies?
Shares of Dynavax Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Dynavax Technologies have?
As Jul 2024, Dynavax Technologies employs 245 workers.
-
What is Dynavax Technologies's official website?
The official website for Dynavax Technologies is dynavax.com.
-
Where are Dynavax Technologies's headquarters?
Dynavax Technologies is headquartered at 2100 Powell Street, EmeryVille, CA.
-
How can i contact Dynavax Technologies?
Dynavax Technologies's mailing address is 2100 Powell Street, EmeryVille, CA and company can be reached via phone at +51 08485100.
Dynavax Technologies company profile:
Dynavax Technologies Corporation
dynavax.comOTC
245
Drug Manufacturers—Specialty & Generic
Healthcare
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
EmeryVille, CA 94608
:
:
:
